Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEBRIKIZUMAB-LBKZ: 726 Adverse Event Reports & Safety Profile

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra
726
Total FAERS Reports
2 (0.3%)
Deaths Reported
19
Hospitalizations
726
As Primary/Secondary Suspect
4
Disabilities
Prescription
Status

FDA Application: 761306 ·

First Report: 20240101 · Latest Report: 20250919

What Are the Most Common LEBRIKIZUMAB-LBKZ Side Effects?

#1 Most Reported
Injection site pain
89 reports (12.3%)
#2 Most Reported
Conjunctivitis
51 reports (7.0%)
#3 Most Reported
Rash
50 reports (6.9%)

All LEBRIKIZUMAB-LBKZ Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Injection site pain 89 12.3% 0 1
Conjunctivitis 51 7.0% 0 0
Rash 50 6.9% 0 0
Pruritus 47 6.5% 0 1
Eczema 39 5.4% 0 1
Drug ineffective 36 5.0% 0 0
Erythema 34 4.7% 0 1
Dermatitis atopic 32 4.4% 0 3
Urticaria 25 3.4% 0 1
Hypersensitivity 23 3.2% 0 2
Underdose 22 3.0% 0 0
Condition aggravated 19 2.6% 0 0
Eye pruritus 18 2.5% 0 0
Ocular hyperaemia 18 2.5% 0 0
Eye irritation 16 2.2% 0 0
Injection site reaction 16 2.2% 0 0
Eye swelling 14 1.9% 0 0
Nausea 13 1.8% 0 0
Incorrect dose administered 12 1.7% 0 0
Drug hypersensitivity 11 1.5% 0 0

Who Reports LEBRIKIZUMAB-LBKZ Side Effects? Age & Gender Data

Gender: 58.2% female, 41.8% male. Average age: 50.3 years. Most reports from: US. View detailed demographics →

Is LEBRIKIZUMAB-LBKZ Getting Safer? Reports by Year

YearReportsDeathsHosp.
2024 42 0 4
2025 242 1 9

View full timeline →

What Is LEBRIKIZUMAB-LBKZ Used For?

IndicationReports
Product used for unknown indication 353
Dermatitis atopic 312
Eczema 48

LEBRIKIZUMAB-LBKZ vs Alternatives: Which Is Safer?

LEBRIKIZUMAB-LBKZ vs LECANEMAB LEBRIKIZUMAB-LBKZ vs LECANEMAB-IRMB LEBRIKIZUMAB-LBKZ vs LECITHIN\POLOXAMER 407 LEBRIKIZUMAB-LBKZ vs LEDIPASVIR LEBRIKIZUMAB-LBKZ vs LEDIPASVIR\SOFOSBUVIR LEBRIKIZUMAB-LBKZ vs LEFLUNOMIDE LEBRIKIZUMAB-LBKZ vs LEMBOREXANT LEBRIKIZUMAB-LBKZ vs LENACAPAVIR LEBRIKIZUMAB-LBKZ vs LENALIDOMIDE LEBRIKIZUMAB-LBKZ vs LENIOLISIB

Official FDA Label for LEBRIKIZUMAB-LBKZ

Official prescribing information from the FDA-approved drug label.